Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors

Molecular and Cellular Biology

Volumn 22, Issue 20, 2002, Pages 7204-7216

  Lagutina, Irina ^a   Conway, Simon J ^a   Sublett, Jack ^a   Grosveld, Gerard C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; HYBRID PROTEIN; MESSENGER RNA;

ALLELE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CHIMERA; CHROMOSOME TRANSLOCATION; DEVELOPMENTAL DISORDER; DNA SEQUENCE; EMBRYO; EMBRYO DEVELOPMENT; GENE; GENE EXPRESSION; GENE TARGETING; GENOTYPE; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE TUMOR; NEWBORN; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ABNORMALITIES, MULTIPLE; ANIMALS; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GENE TARGETING; HEART; HUMANS; LABOR, OBSTETRIC; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; PAIRED BOX TRANSCRIPTION FACTORS; PHENOTYPE; PREGNANCY; RECOMBINANT FUSION PROTEINS; RHABDOMYOSARCOMA, ALVEOLAR; STEM CELLS; TIME FACTORS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0036787919     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.20.7204-7216.2002     Document Type: Article

References (49)

1. Anderson, J., T. Gordon, A. McManus, T. Mapp, S. Gould, A. Kelsey, H. McDowell, R. Pinkerton, J. Shipley, and K. Pritchard-Jones. 2001. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Br. J. Cancer 85:831-835.
2. Anderson, J., A. Ramsay, S. Gould, and K. Pritchard-Jones. 2001. PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma. Am. J. Pathol. 159:1089-1096.
3. Anderson, M. J., G. D. Shelton, W. K. Cavenee, and K. C. Arden. 2001. Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3. Proc. Natl. Acad. Sci. USA 98:1589-1594.
4. Barr, F. G., N. Galili, J. Holick J. A. Biegel, G. Rovera, and B. S. Emanuel. 1993. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 3:113-117.
5. Bennicelli, J. L., S. Advani, B. W. Schafer, and F. G. Barr. 1999. PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma. Oncogene 18:4348-4356.
6. Bennicelli, J. L., R. H. Edwards, and F. G. Barr. 1996. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Proc. Natl. Acad. Sci. USA 93:5455-5459.
7. Bober, E., T. Franz, H. H. Arnold, P. Gruss, and P. Tremblay. 1994. Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development 120:603-612.
8. Boehm, T., L. Mengle-Gaw, U. R. Kees, N. Spurr, I. Lavenir, A. Forster, and T. H. Rabbitts. 1989. Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. EMBO J. 8:2621-2631.
9. Buckingham, M. 2001. Skeletal muscle formation in vertebrates. Curr. Opin. Genet. Dev. 11:440-448.
10. Cao, Y., and C. Wang. 2000. The COOH-terminal transactivation domain plays a key role in regulating the in vitro and in vivo function of Pax3 homeodomain. J. Biol. Chem. 275:9854-9862.
11. Christ, B., and C. P. Ordahl. 1995. Early stages of chick somite development. Anat. Embryol. (Berlin) 191:381-396.
12. Collins, M. H., H. Zhao, R. B. Womer, and F. G. Barr. 2001. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions. Med. Pediatr. Oncol. 37:83-89.
13. Conway, S. J., R. E. Godt, C. J. Hatcher, L. Leatherbury, V. V. Zolotouchnikov, M. A. Brotto, A. J. Copp, M. L. Kirby, and T. L. Creazzo. 1997. Neural crest is involved in development of abnormal myocardial function. J. Mol. Cell. Cardiol. 29:2675-2685.
14. Couly, G. F., P. M. Coltey, and N. M. Le Douarin. 1993. The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. Development 117:409-429.
15. Daston, G., E. Lamar, M. Olivier, and M. Goulding. 1996. Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development 122:1017-1027.
16. Davis, R. J., C. M. D'Cruz, M. A. Lovell, J. A. Biegel, and F. G. Barr. 1994. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 54:2869-2872.
17. Denetclaw, W. F., Jr., B. Christ, and C. P. Ordahl. 1997. Location and growth of epaxial myotome precursor cells. Development 124:1601-1610.
18. Denetclaw, W. F., and C. P. Ordahl. 2000. The growth of the dermomyotome and formation of early myotome lineages in thoracolumbar somites of chicken embryos. Development 127:893-905.
19. Dent, J. A., A. G. Polson, and M. W. Klymkowsky. 1989. A whole-mount immunocytochemical analysis of the expression of the intermediate filament protein vimentin in Xenopus. Development 105:61-74.
20. Franz, T. 1989. Persistent truncus arteriosus in the Splotch mutant mouse. Anat. Embryol. (Berlin) 180:457-464.
21. Franz, T., R. Kothary, M. A. Surani, Z. Halata, and M. Grim. 1993. The Splotch mutation interferes with muscle development in the limbs. Anat. Embryol. (Berlin) 187:153-160.
22. Furuyama, T., T. Nakazawa, I. Nakano, and N. Mori. 2000. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 349:629-634.
23. Galili, N., R. J. Davis, W. J. Fredericks, S. Mukhopadhyay, F. J. Rauscher, 3rd, B. S. Emanuel, G. Rovera, and F. G. Barr. 1993. Fusion of a fork head domain gene to PAX3 in the solid turnout alveolar rhabdomyosarcoma. Nat. Genet. 5:230-235.
24. Goulding, M., A. Lumsden, and A. J. Paquette. 1994. Regulation of Pax-3 expression in the dermomyotome and its role in muscle development. Development 120:957-971.
25. Goulding, M., S. Sterrer, J. Fleming, R. Balling, J. Nadeau, K. J. Moore, S. D. Brown, K. P. Steel, and P. Gruss. 1993. Analysis of the Pax-3 gene in the mouse mutant splotch. Genomics 17:355-363.
26. Goulding, M. D., G. Chalepakis, U. Deutsch, J. R. Erselius, and P. Gruss. 1991. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10:1135-1147.
27. Hollenbach, A. D., J. E. Sublett, C. J. McPherson, and G. Grosveld. 1999. The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. EMBO J. 18:3702-3711.
28. Holzenberger, M., P. Leneuve, G. Hamard, B. Ducos, L. Perin, M. Binoux, and Y. Le Bouc. 2000. A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit. Endocrinology 141:2557-2566.
29. Humpherys, D., K. Eggan, H. Akutsu, K. Hochedlinger, W. M. Rideout III, D. Biniszkiewicz, R. Yanagimachi, and R. Jaenisch. 2001. Epigenetic instability in ES cells and cloned mice. Science 293:95-97.
30. Jiang, X., D. H. Rowitch, P. Soriano, A. P. McMahon, and H. M. Sucov. 2000. Fate of the mammalian cardiac neural crest. Development 127:1607-1616.
31. Jostes, B., C. Walther, and P. Gruss. 1990. The murine paired box gene, Pax7, is expressed specifically during the development of the nervous and muscular system. Mech. Dev. 33:27-37.
32. Khan, J., R. Simon, M. Bittner, Y. Chen, S. B. Leighton, T. Pohida, P. D. Smith, Y. Jiang, G. C. Gooden, J. M. Trent, and P. S. Meltzer. 1998. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58:5009-5013.
33. Lam, P. Y., J. E. Sublett, A. D. Hollenbach, and M. F. Roussel. 1999. The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain. Mol. Cell. Biol. 19:594-601.
34. McCarville, M. B., S. L. Spunt, and A. S. Pappo. 2001. Rhabdomyosarcoma in pediatric patients: the good, the bad, and the unusual. Am. J. Roentgenol. 176:1563-1569.
35. Moss, A. 1989. Heart disease in infants, children, and adolescents, 4th ed. The Williams & Wilkins Co., Baltimore.
36. Newton, W. A., Jr., E. A. Gehan, B. L. Webber, H. B. Marsden, A. J. van Unnik, A. B. Hamoudi, M. G. Tsokos, H. Shimada, D. Harms, D. Schmidt, et al. 1995. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification - an Intergroup Rhabdomyosarcoma Study. Cancer 76:1073-1085.
37. Noden, D. M. 1983. The embryonic origins of avian cephalic and cervical muscles and associated connective tissues. Am. J. Anat. 168:257-276.
38. Oliver, G., A. Mailhos, R. Wehr, N. G. Copeland, N. A. Jenkins, and P. Gruss. 1995. Six3, a murine homologue of the sine oculis gene, demarcates the most anterior border of the developing neural plate and is expressed during eye development. Development 121:4045-4055.
39. Pappo, A. S., D. N. Shapiro, W. M. Crist, and H. M. Maurer. 1995. Biology and therapy of pediatric rhabdomyosarcoma. J. Clin. Oncol. 13:2123-2139.
40. Ridgeway, A. G., and I. S. Skerjanc. 2001. Pax3 is essential for skeletal myogenesis and the expression of Six1 and Eya2. J. Biol. Chem. 276:19033-19039.
41. Rohwedel, J., V. Maltsev, E. Bober, H. H. Arnold, J. Hescheler, and A. M. Wobus. 1994. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev. Biol. 164:87-101.
42. Scheidler, S., W. J. Fredericks, F. J. Rauscher III, F. G. Barr, and P. K. Vogt. 1996. The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. Proc. Natl. Acad. Sci. USA 93:9805-9809.
43. Seale, P., L. A. Sabourin, A. Girgis-Gabardo, A. Mansouri, P. Gruss, and M. A. Rudnicki. 2000. Pax7 is required for the specification of myogenic satellite cells. Cell 102:777-786.
44. Shapiro, D. N., J. E. Sublett, B. Li, J. R. Downing, and C. W. Naeve. 1993. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53:5108-5112.
45. Tajbakhsh, S., and M. Buckingham. 2000. The birth of muscle progenitor cells in the mouse: spatiotemporal considerations. Curr. Top. Dev. Biol. 48:225-268.
46. Tremblay, P., S. Dietrich, M. Mericskay, F. R. Schubert, Z. Li, and D. Paulin. 1998. A crucial role for Pax3 in the development of the hypaxial musculature and the long-range migration of muscle precursors. Dev. Biol. 203:49-61.
47. Trent, J., J. Casper, P. Meltzer, F. Thompson, and J. Fogh. 1985. Nonrandom chromosome alterations in rhabdomyosarcoma. Cancer Genet. Cytogenet. 16:189-197.
48. 2 arrest and impaired nucleocytoplasmic transport in mouse embryos lacking the protooncogene CAN/Nup 214. EMBO J. 15:5574-5583.
49. Williams, B. A., and C. P. Ordahl. 1994. Pax-3 expression in segmental mesoderm marks early stages in myogenic cell specification. Development 120:785-796.